Scrip Dividend Declaration

RNS Number : 7645H

The MedicX Fund Limited

14 March 2018

 

For immediate release

14 March 2018

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Scrip Dividend Declaration

MedicX Fund (LSE: MXF) announces that, pursuant to its scrip dividend scheme (the "Scrip Dividend Alternative"), elections were received in respect of 2.1 per cent. of the ordinary shares in issue as at the record date of 16 February 2018. Electing shareholders will receive ordinary shares of no par value in the Company ("Shares") in lieu of receiving cash for the March 2018 dividend in respect of the quarter ended 31 December 2017.  Accordingly, 147,245 Shares will be sold out of treasury by the Company on 29 March 2018 to shareholders who elected to participate in the Scrip Dividend Alternative.

The Shares will rank pari passu with the existing ordinary shares.

Following the transaction, the Company is expected to have 436,002,399 ordinary shares in issue, of which 7,021,823 will be held in treasury. Accordingly the total voting rights in issue are expected to be 428,980,576 in the absence of any further transactions in the Company's ordinary shares before 29 March 2018.

In addition the Company has 14,771,668 ordinary shares of no par value remaining under its block listing facility.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

Octopus Healthcare Adviser Limited                                  [phone]

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer       

Buchanan                                                                        [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

 

END

 

 

DIVDZLFFVXFEBBL